Focus

Drug Development Investors: Angels and VC Firms

The RaiseHunt database lists 92 Drug Development investors: 54 angel investors and 38 people at 10 firms. Most list Seed and Series A among their stages; the largest hubs are New York, San Francisco and Boston.

Strongest in New York, San Francisco and Boston

Common stages: Seed and Series A

92
Drug Development investors
54
Angel investors
38
People at VC/PE firms
10
Firms tagged

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

92 Drug Development investors

Showing 81-92

Filters
AB
Andrew Bartynski

operator angel

San Francisco, United States
Operator angel
Healthcare
View profile
LH
Larry Hsu

operator angel

San Francisco, United States
Operator angel
Healthcare
View profile
JS
Jean Stephenne

angel investor

Brussels, Belgium
Angel
Healthcare
View profile
AB
Anurag Bagaria

operator angel

Operator angel
Healthcare
View profile
VP
Vitaly Pirotsky

operator angel

Winthrop, United States
Operator angel
Healthcare
View profile
LR
Lindsay Rosenwald

angel investor

New York, United States
Angel
Healthcare
View profile
JM
Justin M.

Principal, Healthcare Investments

United States
Venture capital
AIHealthcare
View profile
PA
Peter Alff

Venture Partner

New York, United States
Corporate VCVenture capital
ClimateHealthcare
View profile
CS
Caroline Stout

Partner

San Francisco, United States
Venture debt
Healthcare
View profile
AA
Aaqil Anwar

Investor

United States
Corporate VCFamily Office
AIHealthcare
View profile
MC
Marvin Correa

Director

San Francisco, United States
Venture capital
AIHealthcare
View profile
AT
Alexander Tkachenko

Investor

Russia
Venture debt
Healthcare
View profile

Data: RaiseHunt investor dataset · Snapshot 27 August 2026 · How this data is built · Report a correction or request removal